X

Health Care

MRK Earnings: Merck & Co Q2 adj. profit drops on lower sales

Merck & Co. Inc. (NYSE: MRK) on Tuesday reported lower sales and adjusted earnings for the second quarter of 2025.…

Key highlights from UnitedHealth Group’s (UNH) Q2 2025 earnings results

UnitedHealth Group (NYSE: UNH) reported its second quarter 2025 earnings results today. Total revenues were $111.6 billion compared to $98.8…

Earnings Summary: Revvity (RVTY) reports higher Q2 2025 revenues

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for…

Earnings: A snapshot of Thermo Fisher Scientific’s (TMO) Q2 2025 report

Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second…

Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates

Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in…

Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results

Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7…

Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect

Johnson & Johnson's (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on…

Molina Healthcare reports preliminary Q2 2025 financial results

Molina Healthcare Inc. (NYSE: MOH), a managed care company focused on providing healthcare services to low-income individuals, on Monday reported preliminary…

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it…

Earnings Summary: CooperCompanies (COO) reports higher Q2 revenue and profit

Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided…